Demodex Density, Immune Response and Oxidative Stress in Rosacea Patients
NCT02556827 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2015-09-23
Summary
Aim of study is to determine reactive oxygen products and antioxidant capacity with rosacea patients; to measure metalloproteinase level and inflammatory markers of immune response and investigate their corelation with demodex infestation and also investigate the role of photoaging and sebum secretion in rosacea.
Conditions
- Rosacea
Interventions
- OTHER
-
Obtaining a blood sample
Total oxidant capacity (TOC), total antioxidant capacity (TAC), oxidative stress index (OSI), paraoxonase-1 (PON-1), aryl esterase (ARES), myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), matrix metalloproteinase-1 (MMP-1) and matrix metalloproteinase-9 (MMP-9) levels in venous blood were measured.
- DEVICE
-
Reflectance confocal microscopy
1mm2-sized 10 images were taken from right cheek and forehead; the number of demodex, follicle, the number of mite per follicle, the number of infested follicle and the number of mite per infested follicle were calculated with RCM. And photoaging severity were also assessed by using RCM.
- DEVICE
-
Sebumeter
Sebum rate at forehead and right cheek were evaluated with sebumeter
- DEVICE
-
Video dermoscopy
Dermoscopic photoaging scale were assessed by using video dermoscopy.
Sponsors & Collaborators
-
Bezmialem Vakif University
collaborator OTHER -
Istanbul Training and Research Hospital
lead OTHER_GOV
Principal Investigators
-
Tugba Falay · Istanbul Training and Research Hospital
-
Vefa Aslı Erdemir · Istanbul Training and Research Hospital
-
Mehmet Salih Gürel · Istanbul Training and Research Hospital
-
Abdurrahim Kocyigit · Bezmialem Vakif University
-
Duygu Erdil · Istanbul Training and Research Hospital
-
Eray Metin Güler · Bezmialem Vakif University
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2015-11-30
- Completion
- 2015-12-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea
NCT02583009 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of the Facial and Gut Microbiome in Rosacea
NCT03228927 ·Status: UNKNOWN
-
Phototherapy: Not a Cause of Demodicosis
NCT06000189 ·Status: UNKNOWN
-
Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea
NCT01257919 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy in Treatment of Facial Melasma Combined With Thulium 1927-nm Fractional Laser and Topical H2R Antagonist
NCT06313307 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye Syndrome
NCT01917539 ·Status: WITHDRAWN ·Phase: NA
-
Assessing the Quality of Life of Patients With Rosacea
NCT06271135 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients
NCT02052999 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea
NCT00855595 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris
NCT03271021 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea
NCT00989014 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Patients With Blepharitis and Facial Rosacea
NCT00560703 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
NCT01872715 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
NCT05296629 ·Status: COMPLETED ·Phase: PHASE3
-
Social Media Use of Acne Vulgaris Patients: Multicenter, Survey Work
NCT04538703 ·Status: UNKNOWN
-
A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)
NCT05343455 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea
NCT01025635 ·Status: COMPLETED ·Phase: PHASE2
-
A 21 Day Pharmacokinetics Study in Papulopustular Rosacea
NCT02028286 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne
NCT02998671 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
NCT01659853 ·Status: COMPLETED ·Phase: PHASE3
-
In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy
NCT00771355 ·Status: TERMINATED
-
Sebum Collection and Skin Barrier Function Analysis
NCT03112876 ·Status: COMPLETED
-
Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea
NCT03418610 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne
NCT01584674 ·Status: COMPLETED ·Phase: PHASE3
-
Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
NCT01318733 ·Status: COMPLETED ·Phase: PHASE3